PSUN223 The Three Different Clinical Phenotypes of Checkpoint Inhibitor-Induced Diabetes Mellitus

Checkpoint inhibitor-induced diabetes mellitus (CIADM) is a rare but morbid complication of cancer immunotherapies. The most common presentation is acute hyperglycemia and severe insulin deficiency. Our experience managing 25 patients in our new Immune-Related Adverse Events (IRAE) clinic indicates...

Descripción completa

Detalles Bibliográficos
Autores principales: Perlman, Jordan, Mammen, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Endocrine Disruption
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625552/
http://dx.doi.org/10.1210/jendso/bvac150.923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625552/
http://dx.doi.org/10.1210/jendso/bvac150.923

Ejemplares similares